HomeAR&DHetero Labs Ltd walk-in interview for FR&D/ AR&D on 6th April 2024

Hetero Labs Ltd walk-in interview for FR&D/ AR&D on 6th April 2024

HETERO LABS LIMITED is a leading generic pharmaceutical company in India and is one of the largest producers of anti-retroviral drugs worldwide for the treatment of HIV/AIDS. With over 25 years of experience in the pharmaceutical industry, Hetero focuses on APIS, generics, and biosimilars. The company also offers customized pharmaceutical services to partners across the globe. Hetero is known for its expertise in Research and Development, manufacturing, and commercialization of a wide range of products.

Join our expanding team at Hetero Labs Limited! We are hiring for our Formulation R&D department in Hyderabad. Attend our walk-in interview on 6th April 2024. Don’t miss this opportunity! #jobopening #HeteroLabsLimited

Greetings for the day from Hetero Labs Limited. We are expanding our team and we are hiring for our Formulation R&D, Hyderabad. Interested candidates can attend interviews on 6th April’ 2024 (Saturday) at JEEDIMETLA

Walk-in Interview – Formulation R&D

Department: Analytical R&D , Formulation R&D
Experience: 1 to 5 Yrs
Qualification: M.Sc./M.Pharmacy
Job Location: Hyderabad

Walk-In Interview Details:
Date of interview: 6th April, 2024
Time: 9.30 AM – 12.30 PM
Venue: Hetero Labs Limited Unit-VII Sy.No.50 , plot no: 14 , Phase-III , IDA, Jeedimetla, Hyderabad – 500055.

Interested candidates please share profile to edukondalu.m@hetero.com

What to bring to the interview:

  • Academic documents,
  • Pay slips,
  • Appointment letter
  • ID proof along with photo.

Hetero Labs Ltd walk-in interview for FR&D/ AR&D on 6th April 2024

0/5 (0 Reviews)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading